High-Dose Cytarabine in Acute Myeloid Leukemia Treatment: A Systematic Review and Meta-Analysis

The optimal dose, scheme, and clinical setting for Ara-C in acute myeloid leukemia (AML) treatment remain uncertain. In this study, we performed a meta-analysis to systematically assess the impact of high-dose cytarabine (HDAC) on AML therapy during the induction and consolidation stages. Twenty-two...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Wei, Gong, Xiaoyuan, Sun, Mingyuan, Zhao, Xingli, Gong, Benfa, Wei, Hui, Mi, Yingchang, Wang, Jianxiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4192550/
https://www.ncbi.nlm.nih.gov/pubmed/25299623
http://dx.doi.org/10.1371/journal.pone.0110153

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4192550/
https://www.ncbi.nlm.nih.gov/pubmed/25299623
http://dx.doi.org/10.1371/journal.pone.0110153

Ejemplares similares